Warby Parker Quarterly Cash Flow Statements Chart
Quarterly
|
Annual
Warby Parker Quarterly Cash Flow Statements Table
Quarterly
|
Annual
Unit: USD | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash flows from operating activities | |||||||||||||||
net income | -1,752,000 | 3,472,000 | -6,877,000 | -4,072,000 | -6,762,000 | -2,679,000 | -19,047,000 | -17,413,000 | -15,925,000 | -10,812,000 | -20,251,000 | -23,843,000 | -32,166,000 | -34,133,000 | -45,903,000 |
adjustments to reconcile net income to net cash from operating activities: | |||||||||||||||
depreciation and amortization | 12,486,000 | 12,162,000 | 12,332,000 | 11,829,000 | 11,121,000 | 10,583,000 | 10,370,000 | 9,760,000 | 9,284,000 | 9,140,000 | 8,917,000 | 7,930,000 | 7,880,000 | 7,137,000 | 6,546,000 |
stock-based compensation | 8,896,000 | 12,333,000 | 8,630,000 | 10,785,000 | 13,831,000 | 14,048,000 | 16,426,000 | 16,291,000 | 18,012,000 | 19,780,000 | 19,823,000 | 24,301,000 | 26,764,000 | 27,144,000 | 31,146,000 |
non-cash charitable contribution | 0 | 0 | 0 | 2,591,000 | 500,000 | 0 | 0 | ||||||||
asset impairment charges | 175,000 | 311,000 | 294,000 | 101,000 | 22,000 | 399,000 | 1,823,000 | 757,000 | 255,000 | 395,000 | 138,000 | ||||
amortization of cloud-based software implementation costs | 751,000 | 737,000 | 842,000 | 854,000 | 935,000 | 1,073,000 | 1,216,000 | 853,000 | 463,000 | 363,000 | |||||
change in operating assets and liabilities: | |||||||||||||||
accounts receivable | 334,000 | 475,000 | -855,000 | 115,000 | -41,000 | 612,000 | -1,059,000 | 455,000 | -214,000 | 473,000 | -325,000 | -215,000 | -74,000 | 163,000 | -171,000 |
inventory | 5,338,000 | 3,739,000 | 421,000 | 580,000 | 3,104,000 | 5,784,000 | 1,383,000 | -3,817,000 | 4,606,000 | 4,442,000 | 1,728,000 | 182,000 | -6,557,000 | -7,147,000 | -5,653,000 |
prepaid expenses and other assets | -849,000 | 1,934,000 | -2,085,000 | -1,087,000 | 2,852,000 | -2,913,000 | -3,686,000 | -891,000 | 1,958,000 | -657,000 | -5,741,000 | -2,161,000 | 1,931,000 | -4,316,000 | -6,112,000 |
accounts payable | -2,780,000 | 4,626,000 | -12,578,000 | 11,883,000 | -1,943,000 | 3,327,000 | -1,123,000 | 608,000 | 3,069,000 | -921,000 | 1,266,000 | -10,670,000 | 710,000 | 751,000 | -18,743,000 |
accrued expenses | 11,312,000 | -560,000 | 6,793,000 | -2,459,000 | 5,295,000 | -108,000 | -7,691,000 | 10,412,000 | -3,793,000 | -7,826,000 | 7,067,000 | 4,048,000 | -6,209,000 | -2,158,000 | -2,238,000 |
deferred revenue | -991,000 | -9,845,000 | 13,142,000 | -1,836,000 | -188,000 | -10,377,000 | 13,994,000 | -1,321,000 | 60,000 | -6,744,000 | 9,379,000 | -2,034,000 | -1,108,000 | -2,654,000 | 5,296,000 |
lease assets and liabilities | 4,668,000 | -601,000 | |||||||||||||
other liabilities | -210,000 | 575,000 | 146,000 | -77,000 | -81,000 | -87,000 | -99,000 | -103,000 | -109,000 | -97,000 | -148,000 | -110,000 | -287,000 | 2,217,000 | -2,143,000 |
net cash from operating activities | 40,199,000 | 29,358,000 | 19,912,000 | 27,282,000 | 31,623,000 | 19,927,000 | 13,665,000 | 19,931,000 | 18,752,000 | 8,643,000 | 23,839,000 | 1,155,000 | -4,328,000 | -10,296,000 | -31,859,000 |
capex | -16,552,000 | -11,241,000 | -18,854,000 | -12,759,000 | -18,144,000 | -9,855,000 | -15,867,000 | -12,898,000 | -11,831,000 | -9,428,000 | -15,066,000 | -12,857,000 | -16,471,000 | -11,819,000 | -15,583,000 |
free cash flows | 23,647,000 | 18,117,000 | 1,058,000 | 14,523,000 | 13,479,000 | 10,072,000 | -2,202,000 | 7,033,000 | 6,921,000 | -785,000 | 8,773,000 | -11,702,000 | -20,799,000 | -22,115,000 | -47,442,000 |
cash flows from investing activities | |||||||||||||||
purchases of property and equipment | -16,286,000 | -16,152,000 | -17,721,000 | -14,223,000 | -17,651,000 | -14,437,000 | -13,573,000 | -15,488,000 | -12,225,000 | -12,385,000 | -14,215,000 | -14,097,000 | -15,809,000 | -16,060,000 | -14,495,000 |
investment in optical equipment company | 0 | 0 | 0 | -2,000,000 | 0 | ||||||||||
net cash from investing activities | -16,286,000 | -16,152,000 | -17,721,000 | -14,223,000 | -17,651,000 | -16,437,000 | -13,573,000 | -16,488,000 | -12,225,000 | -12,385,000 | -14,215,000 | -14,097,000 | -15,809,000 | -16,060,000 | -14,495,000 |
cash flows from financing activities | |||||||||||||||
proceeds from stock option exercises | 78,000 | 39,000 | 17,000 | 47,000 | 2,548,000 | 91,000 | 174,000 | 762,000 | 81,000 | 67,000 | 48,000 | 180,000 | |||
shares withheld for taxes on stock-based compensation | -4,020,000 | -2,341,000 | |||||||||||||
proceeds from shares issued in connection with employee stock purchase plan | 0 | 0 | 0 | ||||||||||||
net cash from financing activities | -2,773,000 | -2,302,000 | 1,207,000 | 47,000 | 3,616,000 | 91,000 | 730,000 | 174,000 | 1,886,000 | 81,000 | 1,197,000 | 112,000 | 1,802,000 | 180,000 | 36,574,000 |
effect of exchange rates on cash | 170,000 | 9,000 | -267,000 | -32,000 | -14,000 | -91,000 | 107,000 | -308,000 | -19,000 | -662,000 | -121,000 | -888,000 | -386,000 | 84,000 | -41,000 |
net change in cash and cash equivalents | 21,310,000 | 10,913,000 | 13,074,000 | 17,574,000 | 3,490,000 | 3,309,000 | |||||||||
cash and cash equivalents, beginning of period | 0 | 254,161,000 | 0 | 0 | 216,894,000 | 0 | 0 | 208,585,000 | 0 | ||||||
cash and cash equivalents, end of period | 21,310,000 | 265,074,000 | 13,074,000 | 17,574,000 | 220,384,000 | 3,309,000 | 8,394,000 | 204,262,000 | -13,718,000 | ||||||
supplemental disclosures | |||||||||||||||
cash paid for income taxes | 606,000 | 37,000 | 253,000 | 437,000 | 276,000 | 69,000 | 19,000 | 74,000 | 229,000 | 97,000 | 65,000 | 174,000 | 263,000 | 34,000 | 42,000 |
cash paid for interest | 72,000 | 104,000 | 77,000 | 77,000 | 16,000 | 76,000 | 72,000 | 45,000 | 60,000 | 50,000 | 95,000 | 27,000 | 27,000 | 35,000 | 56,000 |
non-cash investing and financing activities: | |||||||||||||||
purchases of property and equipment included in accounts payable and accrued expenses | -266,000 | 4,911,000 | -1,133,000 | 1,464,000 | -493,000 | 4,582,000 | -2,294,000 | 2,590,000 | 394,000 | 2,957,000 | -851,000 | 1,240,000 | -662,000 | 4,241,000 | -1,088,000 |
proceeds from shares issued in connection with espp | |||||||||||||||
other financing activity | |||||||||||||||
net increase in cash and cash equivalents | -9,821,000 | ||||||||||||||
cash and cash equivalents | |||||||||||||||
beginning of year | 256,416,000 | 0 | |||||||||||||
end of year | 230,324,000 | -9,821,000 | |||||||||||||
cash paid for amounts included in the measurement of lease liabilities | 22,791,000 | 467,000 | 10,801,000 | 10,400,000 | 10,002,000 | 9,594,000 | 6,681,000 | 10,849,000 | |||||||
other current liabilities | 153,000 | -937,000 | 528,000 | 157,000 | -95,000 | -140,000 | 119,000 | 447,000 | -143,000 | 104,000 | 129,000 | 1,000 | |||
right-of-use lease assets and current and non-current lease liabilities | 513,000 | 2,219,000 | -263,000 | 1,001,000 | 1,844,000 | 626,000 | 988,000 | 1,039,000 | 2,361,000 | 1,414,000 | 2,571,000 | ||||
deferred rent | 5,567,000 | ||||||||||||||
proceeds from stock option and warrant exercises | 9,948,000 | ||||||||||||||
employee tax withholding remitted in connection with exercise or release of equity awards | 26,527,000 | ||||||||||||||
proceeds from repayment of related party loans | 46,000 | 99,000 | |||||||||||||
repurchase of stock | |||||||||||||||
payment for tender offer | 0 | ||||||||||||||
related party loans issued in connection with stock option exercises | 0 | ||||||||||||||
net decrease in cash and cash equivalents | -4,323,000 | -13,718,000 | -18,721,000 | -26,092,000 | |||||||||||
issuance of series f redeemable convertible preferred stock, net of issuance costs | |||||||||||||||
issuance of series g redeemable convertible preferred stock, net of issuance costs | |||||||||||||||
borrowings from credit facility | |||||||||||||||
repayment of credit facility | |||||||||||||||
stock repurchases | |||||||||||||||
cancellation of options for consideration | |||||||||||||||
other non-current assets |
We provide you with 20 years of cash flow statements for Warby Parker stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as operating cash flows, cash levels, capital expenditures, profits, stock-based compensations and profit margins. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of Warby Parker stock. Explore the full financial landscape of Warby Parker stock with our expertly curated income statements.
The information provided in this report about Warby Parker stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.